Trade wars aren't won with spreadsheets; they're won with nerves. If you've been tracking the back-and-forth between New Delhi and Washington lately, you know the atmosphere is thick with more than just smog. JPMorgan's latest analysis suggests that US tariffs on Indian exports are likely to settle into a 15% to 17% range. This isn't just a random number pulled from a hat. It's the result of a high-stakes legal and political collision between President Trump's "reciprocal tariff" ambitions and the cold reality of the US court system.
For months, Indian exporters were staring down the barrel of a 50% duty—a combination of a 25% baseline and an extra 25% "penalty" for India's continued appetite for Russian oil. That's a death sentence for most margins. But the landscape shifted dramatically in February 2026. A US Supreme Court ruling basically told the White House it couldn't use emergency powers (specifically the IEEPA) to tax the world at will.
So, where does that leave us? Basically, we're in a "rebalancing" phase. While the 50% nightmare has faded, the "10% for 150 days" baseline under Section 122 of the Trade Act of 1974 is already morphing. Trump has already signaled an upward tick to 15%, and when you layer on the existing Most Favored Nation (MFN) duties, JPMorgan's 15% to 17% estimate is the most realistic floor we've seen in a year.
The 15 Percent Floor and Why It Matters
You can't just look at the headline tariff and think you've got the whole story. The math is more annoying than that. If a product already has a 2% MFN duty and the US slaps on a 15% "balance-of-payments" tariff, you're looking at 17%. That’s the "effective rate" that actually hits the bank accounts of mid-sized US businesses and Indian manufacturers.
JPMorgan's research highlights a point the White House usually ignores: it's the American companies paying these bills, not the foreign ones. Mid-sized US firms have seen their tariff payments triple over the last year. These are the guys who don't have the "pricing power" of a giant like Apple or Walmart. They can't just squeeze their suppliers or raise prices 20% without losing customers. They’re the ones feeling the 15% to 17% pinch most acutely.
Sector Winners and Losers
- Pharmaceuticals: This is India's crown jewel in the US market. Around 40% of US generic drugs come from India. Even with an 18% tariff framework discussed in the recent trade deal, pharma is relatively "inelastic." People need their meds. But a sustained 17% rate will eventually push US healthcare costs up, likely by about 13% for certain drug categories.
- IT and Services: Here’s the good news. Software and services aren't physical goods, so they don't get hit by customs duties. If you’re exporting code, you’re safe from the 15% levy. However, the sentiment matters. Policy uncertainty makes US clients hesitate on long-term 5-year contracts.
- Textiles and Leather: These guys are hurting. These are low-margin businesses. A 15% shift can wipe out an entire year's profit. Many Indian exporters in this space were offering 15% discounts just to keep their US buyers from fleeing to Vietnam or Bangladesh.
The Russian Oil Factor
Let’s be honest about why India was in the crosshairs to begin with. The US wasn't just mad about trade deficits; they were mad about the Kremlin. The original 50% tariff was a blunt instrument to force India to stop buying Russian crude.
The framework deal reached on February 6, 2026, saw Prime Minister Modi essentially agree to pivot. India pledged to wind down Russian oil imports in exchange for the US rolling back the punitive 25% "penalty" layer. This move alone saved the bilateral relationship from a total meltdown. It also paved the way for the "Pax Silica" initiative—a fancy way of saying India is now officially part of the US-led high-tech supply chain meant to rival China.
Why the Supreme Court Threw a Wrench in the Works
The US Supreme Court's 6-3 decision in Learning Resources, Inc. v. Trump changed the game. By ruling that the President can't use the International Emergency Economic Powers Act (IEEPA) to impose tariffs, they stripped away the "reciprocal tariff" logic that Trump used to justify the initial 25% and 50% rates.
This created a temporary vacuum. For a few days, tariffs on Indian goods effectively dropped back to MFN levels. But don't think for a second the administration is giving up. They immediately pivoted to Section 122, which allows for a 15% tariff for 150 days to deal with "balance-of-payments" issues. This is why we're seeing the 15% to 17% range now. It's the most the President can legally grab without a specific new law from Congress.
What Happens After 150 Days?
That’s the $500 billion question. The 150-day window is a pressure cooker. It's designed to force India to sign the "Interim Trade Agreement" before the clock runs out. If the deal is signed, we might see tariffs on specific "sensitive" items—like gems, jewelry, and aircraft parts—drop to zero or near-zero. If the negotiations stall, the US might try to move toward Section 232 (national security) or Section 301 (unfair trade practices) investigations to keep the pressure on.
Stop Overthinking the Volatility
If you’re an exporter or an investor, the "wait and see" approach is a trap. Volatility is the new baseline. Commerce Minister Piyush Goyal has already said India is ready to "rebalance" the deal if the US keeps moving the goalposts.
You need to look at the "weighted average." Even if the headline says 15%, the actual impact across the Nifty 50 companies varies wildly. Companies like Sun Pharma or Dr. Reddy’s have already priced in a certain level of disruption. The real risk is for the smaller, unlisted exporters who don't have the legal teams to navigate US Customs and Border Protection (CBP) refunds or reclassification.
Practical Steps for Navigating the 15-17% Reality
- Audit your HTS codes: Don't just accept the blanket rate. The US Supreme Court ruling left Section 232 and Section 301 tariffs intact. Make sure your products aren't being double-taxed under old investigations that were never officially cleared.
- Review your "Force Majeure" clauses: Most contracts don't cover a 15% sudden tax hike. You need to renegotiate who bears the burden of these "balance-of-payments" duties before the next 150-day cycle ends.
- Watch the Energy Pivot: The reduction in tariffs is tied to India’s commitment to buy $500 billion in US energy and tech. If those purchase orders don't materialize, expect the US to trigger "snapback" provisions that could push rates back toward 25%.
The JPMorgan report isn't a warning; it's a map. The era of 2% duties is over, but the 50% panic is also behind us. Success now depends on how well you can operate in that 15% to 17% "middle ground." It’s tight, it’s annoying, but for the most resilient players in the India-US corridor, it’s still a profitable place to be.
Start by recalculating your landed cost with a 16.5% average duty and see if your business model still breathes. If it doesn't, it's time to find a new market or a more efficient way to produce. The "tariff drama," as some exporters call it, isn't ending—it’s just changing acts.
